ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 180 filers reported holding ABCELLERA BIOLOGICS INC in Q1 2023. The put-call ratio across all filers is 0.20 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $9,102 | -98.6% | 1,409 | -98.4% | 0.00% | – |
| Q1 2023 | $650,974 | +14.2% | 86,336 | +53.5% | 0.00% | – |
| Q4 2022 | $569,873 | -47.4% | 56,256 | -48.6% | 0.00% | – |
| Q3 2022 | $1,083,000 | +178.4% | 109,533 | +199.8% | 0.00% | – |
| Q2 2022 | $389,000 | -50.7% | 36,539 | -33.8% | 0.00% | – |
| Q4 2021 | $789,000 | -31.1% | 55,200 | -3.3% | 0.00% | – |
| Q3 2021 | $1,145,000 | -10.4% | 57,100 | -1.7% | 0.00% | – |
| Q2 2021 | $1,278,000 | -39.0% | 58,100 | -5.8% | 0.00% | – |
| Q1 2021 | $2,095,000 | -79.9% | 61,700 | -76.1% | 0.00% | -100.0% |
| Q4 2020 | $10,406,000 | – | 258,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Fund VII Management, LLC | 3,773,530 | $37,320,000 | 92.58% |
| Gruss & Co., LLC | 308,570 | $3,052,000 | 26.27% |
| Founders Fund Growth Management, LLC | 407,017 | $4,025,000 | 11.55% |
| Belmont Capital, LLC | 510,000 | $5,044,000 | 5.95% |
| HARVARD MANAGEMENT CO INC | 4,105,095 | $40,599,000 | 5.05% |
| GUARDIAN CAPITAL ADVISORS LP | 3,736,414 | $40,129,000 | 5.01% |
| Intellectus Partners, LLC | 1,091,505 | $10,795,000 | 3.84% |
| ArchPoint Investors | 617,213 | $6,104,000 | 2.49% |
| BRANDYWINE MANAGERS, LLC | 56,976 | $563,000 | 1.85% |
| Casdin Capital, LLC | 1,650,000 | $16,319,000 | 1.07% |